BIOMAT Database Logo BIOMAT Database Logo

Induction chemotherapy with cisplatin and continuous infusion 5-fluorouracil in locally far-advanced head and neck cancer. 1989

J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Department of Medical Oncology, Rotterdam Cancer Institute, The Netherlands.

Induction combination chemotherapy with cisplatin, 100 mg/m2 i.v. day 1, and 5-fluorouracil, 1,000 mg/m2/24-h infusion days 1-4, was applied in 76 patients with locally far advanced squamous-cell cancer of the head and neck. The treatment program consisted of 3 cycles of chemotherapy, followed by local radiotherapy and/or surgery. Hematologic side effects were leukocytopenia (50%) and thrombocytopenia (35%). Other side effects included renal toxicity (23%), nausea and/or vomiting (86%), alopecia (18%), and phlebitis (45%). Thirteen patients (17%) achieved a complete remission and 37 patients (49%) a partial remission. Median progression-free and overall survival were 8 and 11 months, respectively. Only patients achieving a complete remission had a better prognosis. Although induction chemotherapy may facilitate further local treatment in about half of the patients, on the basis of presently available data, this procedure should not be routinely applied with the aim of better survival.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Four days' continuous infusion of cisplatin-5-fluorouracil and short daily infusion of high-dose leucovorin as induction chemotherapy for locally advanced head and neck cancer.
January 1995, The Journal of infusional chemotherapy,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil, both in continuous 96-hour infusion, in the treatment of locally advanced head and neck cancer.
February 1994, American journal of clinical oncology,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma.
April 1991, American journal of clinical oncology,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Toxicity of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for advanced head and neck cancer.
May 2013, The Israel Medical Association journal : IMAJ,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer.
February 1989, European journal of cancer & clinical oncology,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Is taxane-cisplatin-fluorouracil superior to cisplatin-fluorouracil as induction chemotherapy in outcome in locally advanced head and neck cancers?
January 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancer.
October 2020, Molecular and clinical oncology,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Long-term continuous 5-fluorouracil infusion in patients with advanced head and neck cancer.
January 1999, Acta oncologica (Stockholm, Sweden),
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer.
May 1989, Cancer,
J Verweij, and P C de Jong, and P H de Mulder, and P van der Broek, and J Alexieva-Figusch, and W L van Putten, and J H Schornagel, and L A Ravasz, and G B Snow, and J B Vermorken
5-Fluorouracil and Cisplatin (FP) with Concurrent Radiotherapy for Locally Advanced Head and Neck Cancer.
August 2002, Cancer research and treatment,
Copied contents to your clipboard!